Skip Navigation

Behind the Breakthroughs

  • Upcoming Events

    From the comfort of your own home, join the discussion with leading physician-scientists to learn how Dana-Farber's advancements in cancer research and care are possible because of your support.

  • Community Benefits Upcoming

    Learn how Dana-Farber is delivering expert cancer care and screening directly to underserved populations to disrupt disparities and enhance the health of our community.

  • Past Programs

    Click below to view each recording

  • Telehealth Past

    Join the conversation to understand how Dana-Farber delivered as many as 3,000 telemedicine visits per week in immediate response to the pandemic and continues to lead in this area for patients. Hear directly from Dana-Farber’s expert physician-scientists about virtual visits, ethical and legislative factors, and where we go from here.

  • Count Me In Past

    Count Me In is a research initiative pursuing an innovative, patient-partnered approach to cancer research. Hear from Dana-Farber Cancer Institute’s Nikhil Wagle, MD, Director of Count Me In, to learn how this initiative is bringing patients and researchers together as partners to accelerate discoveries — allowing cancer patients anywhere in the United States or Canada to safely and easily share their medical information, personal experience, and tumor samples for genetic analysis, propelling progress against cancer.

  • exercise and nutrition past

    Learn how Dana-Farber's physician-scientists are combining groundbreaking discovery science research with clinical studies to understand the role of exercise in cancer prevention and treatment.

  • pop sci past

    In this webinar, you will hear about the innovative work of the Division of Population Science which spans numerous cancer disciplines including innovations in early cancer detection technology using sensitive blood biopsies, the application of molecular data to model cancer risk, interventions to promote patient health through tailored exercise programs, and DFCI’s approach to understanding the effects of COVID-19 on cancer care.

  • Red Sox Past

    A conversation with Red Sox executives, Sam Kennedy and Larry Lucchino, and Dana-Farber physician, Lisa Diller, to discuss the history of the 67-year long relationship between the Jimmy Fund and the Red Sox and its impact on pediatric patients in Dana-Farber’s Jimmy Fund Clinic.

  • immunocompromised past

    Hear from Paul Richardson, MD, as he discusses living with and caring for immunocompromised patients in the COVID-19 era.

  • Survivorship Past

    Led by Dana-Farber’s survivorship experts, learn about our commitment to fulfilling the unique physical and psychosocial needs of patients after a cancer diagnosis, and hear the inspiring stories of survivors.

  • AI Past

    Learn how Dana-Farber physician-scientists are harnessing the power of data to predict patient outcomes faster and more proactively than ever before.

  • Childhood Cancer Past

    Learn about how pediatric cancer research at Dana-Farber is aiding the fight against COVID-19 and how we are adapting the patient experience to continue to provide the best care for children with cancer.

  • Collaborating in Cancer_Past

    Learn how seven institutions across Boston are coming together to advance treatments for cancer patients.

  • Nurses Week_Past

    The World Health Organization has named 2020 the Year of the Nurse. Join us during National Nurses Week to learn how Dana-Farber is transforming the practice of nursing in the midst of a global pandemic, while cultivating the next generation of oncology nurses.

  • BC Prevention Past

    Learn how leaders of the Susan F. Smith Center for Women’s Cancers are mitigating risk and minimizing recurrence for breast cancer patients.

  • Steven Corsello MD

    Learn how Dr. Steven Corsello is testing thousands of non-oncology drugs for their potential to treat cancer.

  • 0430 Recording

    Learn how Dana-Farber is discovering ways to detect cancer more quickly and identify, monitor, and support those at greatest risk.

  • 4 - metastatic

    Leaders of the Susan F. Smith Center for Women’s Cancers share updates on their groundbreaking work in metastatic breast cancer and how this work is providing new treatments for breast cancer patients.

  • 5 - Breast Immuno

    Leaders of the Susan F. Smith Center for Women’s Cancers share updates on their groundbreaking work in immunotherapies and how this work is providing new treatments for breast cancer patients.

  • Top

    Leaders of Dana-Farber Cancer Institute share updates on our efforts to keep our patients, faculty, and staff safe as we remain undeterred from our mission to provide expert compassionate cancer care and research.

  • 7 - CSO Recording

    Hear how William G. Kaelin Jr., MD, a researcher at Dana-Farber, won the 2019 Nobel Prize for discoveries of how cells sense and adapt to oxygen availability. Dr. Kaelin discusses how these findings have led to new therapeutics for a wide range of disorders, including cancer.